학술논문
1078TiP Phase I/II, open-label study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of SNS-101 (anti-VISTA) as monotherapy and in combination with cemiplimab in patients (pts) with advanced solid tumors
Document Type
Abstract
Source
In Annals of Oncology October 2023 34 Supplement 2:S649-S649
Subject
Language
ISSN
0923-7534